Samsara Inc. financial statements

Income statement, balance sheet and cash flow statement for the last 6 fiscal years, taken from the XBRL data Samsara Inc. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2021	FY2023	FY2023	FY2024	FY2025	FY2026
Revenue	250	428	653	937	1,249	1,619
Cost of revenue	75.4	124	183	247	298	377
Gross profit	175	304	470	690	951	1,242
Research and development	99.7	205	187	259	300	345
Selling and marketing	202	291	370	487	602	684
General and administrative	75.2	160	171	195	235	266
Operating expenses	384	658	729	1,014	1,141	1,295
Operating income	-209	-354	-259	-323	-190	-52.6
Other non-operating income	-0.64	-0	15.6	40	39.6	53.5
Pre-tax income	-210	-354	-244	-283	-150	0.91
Income tax	0.09	1.17	3.59	3.34	4.49	10
Net income	-210	-355	-247	-287	-155	-9.12
EBITDA	-199	-343	-248	-308	-169	-28.5
EPS, basic	-0.92	-1.28	-0.48	-0.54	-0.28	-0.02
EPS, diluted	-0.92	-1.28	-0.48	-0.54	-0.28	-0.02
Shares, basic (weighted)	239	278	514	535	556	573
Shares, diluted (weighted)	239	278	514	535	556	573

Balance sheet

	FY2021	FY2023	FY2023	FY2024	FY2025	FY2026
Cash and equivalents	434	921	201	136	228	319
Receivables		82	123	162	234	321
Inventory		33.1	40.6	22.2	38.9	48.2
Other current assets		11.4	22.2	51.2	58.1	75.3
Total current assets		1,100	958	887	1,212	1,507
Property, plant and equipment		36.8	59.3	55	58.2	81.6
Lease right-of-use assets		134	113	82	64.9	60.3
Other non-current assets		14.4	16.4	7.23	2.99	14.9
Total assets		1,568	1,617	1,735	2,024	2,541
Accounts payable		54.7	30.1	46.3	64	47.7
Deferred revenue		203	300	426	563	679
Total current liabilities		338	442	592	761	917
Lease liabilities		124	101	78.8	64.6	60.2
Other non-current liabilities		6.69	9.51	9.94	6.62	13.3
Total liabilities		579	679	820	955	1,120
Paid-in capital		1,910	2,107	2,369	2,680	3,035
Retained earnings		-921	-1,168	-1,455	-1,610	-1,619
Other comprehensive income		-0.1	-0.65	1.62	-0.85	4.36
Shareholders' equity	-533	989	938	915	1,069	1,420
Total equity	-533	989	938	915	1,069	1,420
Total liabilities and equity		1,568	1,617	1,735	2,024	2,541

Cash flow statement

	FY2021	FY2023	FY2023	FY2024	FY2025	FY2026
Net income	-210	-355	-247	-287	-155	-9.12
Depreciation and amortization	10.7	10.4	11.8	15.5	20.6	24
Stock-based compensation	25.6	229	177	237	278	315
Deferred income tax	-0.3	1.04	2	0.93	2.07	6.17
Change in receivables	-14.1	-47	-47.5	-46.4	-75.5	-145
Change in inventory	2.84	-19.4	-7.5	18.3	-22.4	-19.1
Cash from operations	-172	-171	-103	-11.8	132	236
Capital expenditures	-32.1	-19.4	-33.2	-11	-20.2	-28.8
Purchases of investments	0	0	-686	-741	-649	-873
Sales and maturities of investments	0	0	86.6	665	602	714
Cash from investing	-32.2	-20	-632	-78.7	-66.6	-190
Share buybacks	-0.06	-0.01	0	0
Cash from financing	402	702	14.2	21	27.1	29.9
Exchange rate effect	0	-0.13	0.11	0.48	-1.08
Net change in cash	198	510	-721	-69	91.1	79
Free cash flow	-204	-191	-136	-22.8	111	207
Income taxes paid	0.03	0.47	0.61	2.12	3.46	3.27

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to August 1, 2026; growth uses fiscal years. Valuation uses the share price of $37.96 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	76.4%	Gross profit / revenue.
Operating margin	1.0%	Operating income / revenue.
EBITDA margin	2.7%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	5.6%	Pre-tax income / revenue.
Net margin	4.9%	Net income / revenue.
FCF margin	13.8%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	15.6%	Cash from operations / revenue.
Effective tax rate	12.2%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	5.7%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	3.3%	Net income / average total assets.
Return on invested capital (ROIC)	1.3%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue	20.3%	Research and development expense / revenue.
Stock-based pay / revenue	17.9%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	1.8%	Capital expenditures / revenue.
D&A / revenue	1.6%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	29.6%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	35.4%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	45.3%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	30.6%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	38.3%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	48.1%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	79.4%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow growth, 1y	86.1%	Free cash flow vs the same period a year earlier. Only from a positive base.
Book value growth, 1y	32.9%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	14.8%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets growth, 1y	25.5%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	16.3%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Share count change, 1y	3.1%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	3.7%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	19.1%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	1.62x	Current assets / current liabilities.
Quick ratio	0.65x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.30x	(Cash + short-term investments) / current liabilities.
Liabilities / assets	42.1%	Total liabilities / total assets.
Working capital	$604.7M	Current assets - current liabilities.
Tangible book value	$1.60B	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.67x	Revenue / average total assets.
Fixed asset turnover	21.0x	Revenue / average property, plant and equipment.
Inventory turnover	7.65x	Cost of revenue / average inventory.
Days inventory	48 days	365 x average inventory / cost of revenue.
Receivables turnover	5.47x	Revenue / average receivables.
Days sales outstanding	67 days	365 x average receivables / revenue.
Days payables	34 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	80 days	Days inventory + days sales outstanding - days payables.
FCF conversion	282.1%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	11.4%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$0.15	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$3.13	Revenue / diluted weighted shares.
FCF per share	$0.43	Free cash flow / diluted weighted shares.
Operating cash flow per share	$0.49	Cash from operations / diluted weighted shares.
Book value per share	$2.71	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$2.71	Tangible book value / shares outstanding.
Cash per share	$0.49	(Cash + short-term investments) / shares outstanding.

Valuation

Metric	Value	How it is calculated
Market cap	$22.12B	Share price x shares outstanding.
Enterprise value	$21.83B	Market cap + total debt - cash - short-term investments.
P/E	244x	Market cap / net income. Only when net income is positive.
P/S	12.0x	Market cap / revenue.
P/B	13.8x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	13.8x	Market cap / tangible book value, when positive.
P/FCF	86.6x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	76.7x	Market cap / cash from operations, when positive.
EV/Sales	11.8x	Enterprise value / revenue.
EV/EBIT	1,127x	Enterprise value / operating income, when both are positive.
EV/EBITDA	444x	Enterprise value / EBITDA, when both are positive.
EV/FCF	85.4x	Enterprise value / free cash flow, when both are positive.
FCF yield	1.2%	Free cash flow / market cap.
Earnings yield	0.4%	Net income / market cap (the inverse of P/E).

What was Samsara Inc.'s revenue in fiscal 2026?

Samsara Inc. reported revenue of $1.62B for fiscal 2026, 29.6% higher than the year before.

Was Samsara Inc. profitable in fiscal 2026?

No. It reported a net loss of $9.1M.

How much free cash flow did Samsara Inc. generate in fiscal 2026?

Cash from operations of $236.2M minus capital expenditures of $28.8M left free cash flow of $207.4M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Samsara Inc.